ASTRO 2022: A Novel Approach for Radiotherapy in Orbital Indolent B-Cell Lymphoma
Posted: 11/07/2022 | By: Kayci Reyer

In a study presented by Pinnix et al at the 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting, researchers sought to test the efficacy of a new radiotherapy strategy among patients with orbital indolent B-cell lymphoma (Abstract 3).

Question 1 of 5

Which negative outcome of traditional 24 to 30 Gy radiotherapy led researchers to test a new radiotherapy approach?

Choose 1